Merck Wins Lawsuit on Levothyroxine Saga in France Merck Wins Lawsuit on Levothyroxine Saga in France

Merck has prevailed in a first lawsuit that claimed that switching the formulation of levothyroxine in France caused patients harm. The company still faces further claims, however.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news